Protocol 17X-MC-LLCF: Effect of LY3202626 on Alzheimer's disease progression as measured by cerebral 18F-AV-1451 Tau-PET in mild Alzheimer's disease dementia (2016–2019)
- Grant type:
- Eli Lilly Australia Pty Ltd
- Researchers:
-
-
Mayne Professor of Psychiatry
Medical School (Office & AME)Faculty of Medicine
-
- Funded by:
- Eli Lilly Australia Pty Limited
